Colchicine and Risk of Venous Thromboembolism: A Systematic Review and Meta-analysis of Randomized Controlled Trials

被引：0

作者：

Wang, Michael K. ^{[1
,2
]}

Razeghi, Ghazal ^{[3
]}

Eikelboom, John W. ^{[1
,2
]}

Devereaux, P. J. ^{[1
,2
,4
]}

Budgeon, Charley A. ^{[3
,5
]}

Jacka, Michael J. ^{[6
]}

Wright, David J. ^{[7
]}

Latini, Roberto ^{[8
]}

Conen, David ^{[1
,2
,4
]}

机构：

[1] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada

[2] McMaster Univ, Dept Med, Hamilton, ON, Canada

[3] McMaster Univ, Michael G DeGroote Sch Med, Hamilton, ON, Canada

[4] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada

[5] Univ Western Australia, Sch Populat & Global Hlth, Perth, Australia

[6] Univ Alberta, Edmonton, AB, Canada

[7] Liverpool Heart & Chest Hosp, Liverpool, England

[8] Mario Negri Inst Pharmacol Res IRCCS, Dept Cardiovasc Res, Milan, Italy

来源：

CANADIAN JOURNAL OF CARDIOLOGY | 2024年 / 40卷 / 07期

关键词：

D O I：

10.1016/j.cjca.2023.12.036

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Colchicine is an inexpensive anti-inflammatory drug used for treating gout and pericarditis. Two large randomized controlled trials (RCTs) showed that colchicine prevents adverse cardiovascular outcomes such as myocardial infarction, stroke, and cardiovascular death in patients with coronary artery disease.1,2 Some trials have suggested that there might be a greater risk of venous thromboembolism (VTE) systematic review and meta-analysis of RCTs to determine the effect of colchicine on the risk of VTE.

引用

页码：1344 / 1346

页数：3

共 50 条

[21] Colchicine therapy in patients with coronary artery disease: a systematic review and meta-analysis of randomized controlled trials
Al-Abdouh, Ahmad
Barbarawi, Mahmoud
Khan, Safi U.
Osman, Mohammed
Upadhrasta, Sireesha
Solipuram, Vinod
Abusnina, Waiel
Radaideh, Qais
Zhao, Di
Michos, Erin D.
CORONARY ARTERY DISEASE, 2021, 32 (05) : 441 - 447
[22] Risk of Venous Thromboembolism in Patients with Cancer: A Systematic Review and Meta-Analysis
Horsted, Freesia
West, Joe
Grainge, Matthew J.
PLOS MEDICINE, 2012, 9 (07)
[23] Atopic dermatitis and risk of venous thromboembolism: a systematic review and meta-analysis
Paramiraksa, P.
Chaichan, C.
Patthamalai, P.
Boonsiri, M.
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (11) : S362 - S362
[24] THE EFFECT OF STATINS ON THE RISK OF VENOUS THROMBOEMBOLISM: A SYSTEMATIC REVIEW AND META-ANALYSIS
Ostberg, Sascha
Brunstrom, Mattias
Carlberg, Bo
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A2055 - A2055
[25] The risk of venous thromboembolism in patients with cirrhosis A systematic review and meta-analysis
Ambrosino, Pasquale
Tarantino, Luciano
Di Minno, Giovanni
Paternoster, Mariano
Graziano, Vincenzo
Petitto, Maurizio
Nasto, Aurelio
Di Minno, Matteo Nicola Dario
THROMBOSIS AND HAEMOSTASIS, 2017, 117 (01) : 139 - 148
[26] Heart failure and risk of venous thromboembolism: a systematic review and meta-analysis
Tang, Liang
Wu, Ying-Ying
Lip, Gregory Y. H.
Yin, Ping
Hu, Yu
LANCET HAEMATOLOGY, 2016, 3 (01): : E30 - E44
[27] Ankylosing spondylitis and risk of venous thromboembolism: A systematic review and meta-analysis
Ungprasert, Patompong
Srivali, Narat
Kittanamongkolchai, Wonngarm
LUNG INDIA, 2016, 33 (06) : 642 - 645
[28] Antidepressant Use and Risk of Venous Thromboembolism: A Systematic Review and Meta-Analysis
Wang, Ying
Ye, Zhikang
Liu, Lihong
Cui, Xiangli
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2019, 22 : 57 - 71
[29] Systemic sclerosis and risk of venous thromboembolism: A systematic review and meta-analysis
Ungprasert, Patompong
Srivali, Narat
Kittanamongkolchai, Wonngarm
MODERN RHEUMATOLOGY, 2015, 25 (06) : 893 - 897
[30] Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
Zhu, Gui-Qi
Zou, Zhuo-Lin
Zheng, Ji-Na
Chen, Da-Zhi
Zou, Tian-Tian
Shi, Ke-Qing
Zheng, Ming-Hua
MEDICINE, 2016, 95 (09)

← 1 2 3 4 5 →